Brief: XSpray Pharma Announces Positive FDA Meeting, Plans For Dasynoc NDA Resubmission

Xspray Pharma publ AB

19/09/2024 12:32

Sept 19 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY PHARMA ANNOUNCES POSITIVE FDA MEETING AND PLANS FOR
DASYNOC NDA RESUBMISSION
    * XSPRAY PHARMA AB (PUBL) - TO RESUBMIT DASYNOC NDA IN Q4
2024
    * XSPRAY PHARMA AB (PUBL) - DASYNOC LAUNCH EXPECTED AS EARLY
AS Q1
2025
    * XSPRAY PHARMA AB (PUBL) - INITIATES PRODUCTION OF NEW
DASYNOC
BATCHES
    * XSPRAY PHARMA AB (PUBL) - FDA DECISION ON DASYNOC EXPECTED
WITHIN 2-6 MONTHS OF RESUBMISSION

Source text for Eikon:  ID:nBw1xKV48a 
Further company coverage:  XSPRAY.ST 

 ((Reuters.Briefs@thomsonreuters.com;))